Arrowhead Pharmaceuticals Inc (ARWR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ARWR? Forum Prognose Aktiensplit

Finanzdaten der Arrowhead Pharmaceuticals Inc-Aktie (ARWR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.95% 264.03	256.47	27.77	542.71	2.50
Operating Expenses	5.11% 223.22	212.37	193.32	161.51	163.91
Benefits Costs and Expenses	6.99% 235.76	220.35	206.86	173.09	177.62
Costs And Expenses	6.99% 235.76	220.35	206.86	173.09	177.62
Depreciation and Amortization	0.06% 6.39	6.386	6.223	-	-
Operating Income/Loss	7.48% 40.81	44.11	-165.55	381.20	-161.41
Nonoperating Income/Loss	57.02% -12.54	-7.985	-13.54	-11.59	-13.70
Income/Loss From Continuing Operations Before Tax	21.73% 28.27	36.12	-179.09	369.62	-175.22
Income Tax Expense/Benefit	99.86% 0.029	20.00	-0.437	1.753	0.103
Income/Loss From Continuing Operations After Tax	75.19% 28.24	16.12	-178.65	367.86	-175.22
Net Income/Loss	75.19% 28.24	16.12	-178.65	367.86	-175.22
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	106.44% -2.569	39.87	-3.411	-2.582	-
Basic Average Shares	9,881% 137.04	1.373	139.04	133.36	-4.304
Diluted Average Shares	34,557% 140.71	0.406	139.04	134.48	-4.219
Basic Earnings Per Share	222.22% 0.22	-0.18	-1.26	2.78	-1.25
Diluted Earnings Per Share	222.22% 0.22	-0.18	-1.26	2.75	-1.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%